AAR  Vol.3 No.4 , September 2014
Prevalence of Hyperuricemia among Hospitalized Elderly Patients and Its Association with Metabolic Syndrome
ABSTRACT
There are few data available on the prevalence of hyperuricemia among elderly and its possible association with metabolic syndrome (MetS) so the aim of this study was to assess prevalence of hyperuricemia among hospitalized elderly patients as well as to assess its association with MetS. Cross sectional data from 200 hospitalized elderly patients were analyzed and the results were as follows: the prevalence of hyperuricemia was 21.0% in elderly men and 15.1% in elderly women. Multivariate logistic regression analysis revealed that BMI ≥ 30 (p = 0.031, OR = 1.1), hypertension (p = 0.019, OR = 1.8), high triglycerides level (p = 0.018, OR = 2.9) and hyperuricemia (p = 0.023, OR = 3.7) were independently associated with MetS. The study concluded that the prevalence of hyperuricemia among hospitalized elderly patients was 21.0% in elderly men and 15.1% in elderly women. There was an independent association between hyperuricemia and metabolic syndrome.

Cite this paper
Abdel Rahman, T. (2014) Prevalence of Hyperuricemia among Hospitalized Elderly Patients and Its Association with Metabolic Syndrome. Advances in Aging Research, 3, 329-337. doi: 10.4236/aar.2014.34043.
References
[1]   Edwards, N.L. (2009) The Role of Hyperuricemia in Vascular Disorders. Current Opinion in Rheumatology, 13, 132-137. http://dx.doi.org/10.1097/BOR.0b013e3283257b96

[2]   Wallace, K.L., Riedel, A.A., Joseph-Ridge, N., et al. (2004) Increasing Prevalence of Gout and Hyperuricemia over 10 Years among Older Adults in a Managed Care Population. The Journal of Rheumatology, 13, 1582-1587.

[3]   Singh, J.A., Reddy, S.G. and Kundukulam, J. (2011) Risk Factors for Gout and Prevention: A Systematic Review of the Literature. Current Opinion in Rheumatology, 23, 192-202.

[4]   Rho, Y.H., Choi, S.J., Lee, Y.H., et al. (2005) The Prevalence of Metabolic Syndrome in Patients with Gout: A Multicenter Study. Journal of Korean Medical Science, 20, 1029-1033. http://dx.doi.org/10.3346/jkms.2005.20.6.1029

[5]   Mellen, P.B., Bleyer, A.J., Erlinger, T.P., et al. (2006) Serum Uric Acid Predicts Incident Hypertension in a Biethnic Cohort: The Atherosclerosis Risk in Communities Study. Hypertension, 48, 1037-1042.
http://dx.doi.org/10.1161/01.HYP.0000249768.26560.66

[6]   Zhu, Y., Pandya, B.J. and Choi, H.K. (2012) Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008. The American Journal of Medicine, 125, 679-687.
http://dx.doi.org/10.1016/j.amjmed.2011.09.033

[7]   Chen, S.J., Yen, C.H., Huang, Y.C., et al. (2012) Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome. Plos One, 7, e45693.
http://dx.doi.org/10.1371/journal.pone.0045693

[8]   Jialal, I., Devaraj, S., Adams-Huet, B., et al. (2012) Increased Cellular and Circulating Biomarkers of Oxidative Stress in Nascent Metabolic Syndrome. The Journal of Clinical Endocrinology and Metabolism, 97, E1844-E1850.
http://dx.doi.org/10.1210/jc.2012-2498

[9]   Hulsmans, M., Geeraert, B., De Keyzer, D., et al. (2012) Interleukin-1 Receptor-Associated Kinase-3 Is a Key Inhibitor of Inflammation in Obesity and Metabolic Syndrome. Plos One, 7, e30414.
http://dx.doi.org/10.1371/journal.pone.0030414

[10]   Lee, J.-M., Kim, H.C., Cho, H.M., et al. (2012) Association between Serum Uric Acid Level and Metabolic Syndrome. Journal of Preventive Medicine Public Health, 45, 181-187.

[11]   Ferrara, L.A., Wang, H., Umans, J.G., et al. (2014) Serum Uric Acid Does Not Predict Incident Metabolic Syndrome in a Population with High Prevalence of Obesity. Nutrition, Metabolism and Cardiovascular Diseases.

[12]   Chobanian, A.V., Bakris, G.L., Black, H.R., et al., The National High Blood Pressure Education Program Coordinating Committee (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Journal of the American Medical Association, 289, 2560-2571.

[13]   Kiernan, M. and Winkleby, M.A. (2000) Identifying Patients for Weight-Loss Treatment: An Empirical Evaluation of the NHLBI Obesity Education Initiative Expert Panel Treatment Recommendations. Archives of Internal Medicine, 160, 2169-2176.

[14]   Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al. (2004) Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation, 112, 2735-2752.
http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404

[15]   National Cholesterol Education Program (2002) Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation & Treatment of High Blood Cholesterol in Adults: Final Report. National Cholesterol Education Program, National Heart-Lung- and Blood Institute, National Institutes of Health (NIH) Publication No. 02-5215.

[16]   Zhang, W., Doherty, M., Bardin, T., et al. (2006) EULAR Evidence Based Recommendations for Gout. Part II: Management. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Annals of the Rheumatic Diseases, 65, 1312-1324. http://dx.doi.org/10.1136/ard.2006.055269

[17]   Perez-Ruiz, F. and Liote, F. (2007) Lowering Serum Uric Acid Levels: What Is the Optimal Target for Improving Clinical Outcomes in Gout? Arthritis Rheumatology, 57, 1324-1328.
http://dx.doi.org/10.1002/art.23007

[18]   Lohsoonthorn, V., Dhanamun, B. and Williams, M.A. (2006) Prevalence of Hyperuricemia and Its Relationship with Metabolic Syndrome in Thai Adults Receiving Annual Health Exams. Archives of Medical Research, 13, 883-889.
http://dx.doi.org/10.1016/j.arcmed.2006.03.008

[19]   Uaratanawong, S., Suraamornkul, S., Angkeaw, S., et al. (2011) Prevalence of Hyperuricemia in Bangkok Population. Clinical Rheumatology, 13, 887-893.
http://dx.doi.org/10.1007/s10067-011-1699-0

[20]   Fang, J. and Alderman, M.H. (2000) Serum Uric Acid and Cardiovascular Mortality the NHANES I Epidemiologic Follow-Up Study, 1971-1992. The Journal of the American Medical Association, 283, 2404-2410.
http://dx.doi.org/10.1001/jama.283.18.2404

[21]   Roddy, E., Zhang, W. and Doherty, M. (2007) The Changing Epidemiology of Gout. Nature Clinical Practice Rheumatology, 3, 443-449.
http://dx.doi.org/10.1038/ncprheum0556

[22]   Chang, H.Y., Pan, W.H., Yeh, W.T., et al. (2001) Hyperuricemia and Gout in Taiwan: Results from the Nutritional and Health Survey in Taiwan (1993-1996). The Journal of Rheumatology, 28, 1640-1646.

[23]   Qiu, L., Cheng, X.-Q., Wu, J., et al. (2013) Prevalence of Hyperuricemia and Its Related Risk Factors in Healthy Adults from Northern and Northeastern Chinese Provinces. BMC Public Health, 13, 664.
http://dx.doi.org/10.1186/1471-2458-13-664

[24]   Zhu, Y.Y. (2011) Prevalence of Gout and Hyperuricemia in the US General Population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis & Rheumatism, 63, 3136-3141. http://dx.doi.org/10.1002/art.30520

[25]   Villegas, R., Xiang, Y.B., Elasy, T., et al. (2012) Purine-Rich Foods, Protein Intake and the Prevalence of Hyperuricemia: The Shanghai Men’s Health Study. Nutrition, Metabolism Cardiovascular Diseases, 22, 409-416.

[26]   Conen, D., Wietlisbach, V., Bovet, P., et al. (2004) Prevalence of Hyperuricemia and Relation of Serum Uric Acid with Cardiovascular Risk Factors in a Developing Country. BMC Public Health, 4, 9.

[27]   Hak, A.E. and Choi, H.K. (2008) Menopause, Postmenopausal Hormone Use and Serum Uric Acid Levels in US Women—The Third National Health and Nutrition Examination Survey. Arthritis Research & Therapy, 10, R116.
http://dx.doi.org/10.1186/ar2519

[28]   Yoo, T.W., Sung, K.C., Shin, H.S., et al. (2005) Relationship between Serum Uric Acid Concentration and Insulin Resistance and Metabolic Syndrome. Circulation Journal, 69, 928-933.
http://dx.doi.org/10.1253/circj.69.928

[29]   Lim, J.H., Kim, Y.K., Kim, Y.S., et al. (2010) Relationship between Serum Uric Acid Levels, Metabolic Syndrome and Arterial Stiffness in Korean. Korean Circulation Journal, 40, 314-320. http://dx.doi.org/10.4070/kcj.2010.40.7.314

[30]   Lee, H.J., Park, H.T., Cho, G.J., et al. (2011) Relationship between Uric Acid and Metabolic Syndrome According to Menopausal Status. Gynecological Endocrinology, 27, 406-411. http://dx.doi.org/10.3109/09513590.2010.493962

[31]   Banora, E., Kiechl, S., Willeit, J., et al. (2003) Bruneck Study. Carotid Atherosclerosis and Coronary Heart Disease in the Metabolic Syndrome: Prospective Data from the Bruneck Study. Diabetes Care, 26, 1251-1257.
http://dx.doi.org/10.2337/diacare.26.4.1251

[32]   Johnson, R.J., Kang, D.H., Feig, D., et al. (2003) Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? Hypertension, 41, 1183-1190.
http://dx.doi.org/10.1161/01.HYP.0000069700.62727.C5

[33]   Kanellis, J. and Kang, D.H. (2005) Uric Acid as a Mediator of Endothelial Dysfunction, Inflammation and Vascular Disease. Seminars in Neurology, 25, 39-42.

[34]   Kawamoto, R., Tabara, Y., Kohara, K., et al. (2013) Serum Uric Acid is More Strongly Associated with Impaired Fasting Glucose in Women than in Men from a Community-Dwelling Population. PLoS ONE, 8, e65886.

[35]   Kivity, S., Kopel, E., Steinlauf, S., et al. (2013) The Association between Serum Uric Acid and Diabetes Mellitus Is Stronger in Women. Journal of Women’s Health, 22, 782-789.
http://dx.doi.org/10.1089/jwh.2012.4043

[36]   Bhole, V., Choi, J.W., Kim, S.W., et al. (2010) Serum Uric Acid Levels and the Risk of Type 2 Diabetes: A Prospective Study. American Journal of Medicine, 123, 957-961.

[37]   Dehghan, A., van Hoek, M., Sijbrands, E.J., et al. (2008) High Serum Uric Acid as a Novel Risk Factor for Type 2 Diabetes. Diabetes Care, 31, 361-362.
http://dx.doi.org/10.2337/dc07-1276

[38]   Kramer, C.K., von Muhlen, D., Jassal, S.K. and Barrett-Connor, E. (2009) Serum Uric Acid Levels Improve Prediction of Incident Type 2 Diabetes in Individuals with Impaired Fasting Glucose: The Rancho Bernardo Study. Diabetes Care, 32, 1272-1273.
http://dx.doi.org/10.2337/dc09-0275

[39]   Niskanen, L., Laaksonen, D.E., Lindstrom, J., et al. (2006) Serum Uric Acid as a Harbinger of Metabolic Outcome in Subjects with Impaired Glucose Tolerance: The Finnish Diabetes Prevention Study. Diabetes Care, 29, 709-711.
http://dx.doi.org/10.2337/diacare.29.03.06.dc05-1465

[40]   Choi, H.K., De Vera, M.A. and Krishnan, E. (2008) Gout and the Risk of Type 2 Diabetes among Men with a High Cardiovascular Risk Profile. Rheumatology, 47, 1567-1570.
http://dx.doi.org/10.1093/rheumatology/ken305

[41]   Hayashi, T., Boyko, E.J., Leonetti, D.L., et al. (2004) Visceral Adiposity in as Independent Predictor of Incident Hypertention in Japanese Americans. Annals of Internal Medicine, 140, 992-1000
http://dx.doi.org/10.7326/0003-4819-140-12-200406150-00008

[42]   Sun, N., Zhang, Y., Tian, J.L., et al. (2013) Relationship between Uric Acid and Arterial Stiffness in the Elderly with Metabolic Syndrome Components. Chinese Medical Journal, 126, 3097-3102.

[43]   Dai, X., Yuan, J., Yao, P., et al. (2013) Association between Serum Uric Acid and the Metabolic Syndrome among a Middle- and Old-Age Chinese Population. European Journal of Epidemiology, 28, 669-676.
http://dx.doi.org/10.1007/s10654-013-9829-4

[44]   Keenan, T., Blaha, M.J., Nasir, K., et al. (2012) Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis. American Journal of Cardiology, 110, 1787-1792.
http://dx.doi.org/10.1016/j.amjcard.2012.08.012

[45]   Amin-ul-Haq, Mahmood, R., Ahmad, Z., et al. (2010) Association of Serum Uric Acid with Blood Urea and Serum Creatinine. Pakistan Journal of Physiology, 6, 46-49.

[46]   Choi, H.K., Mount, D.B. and Reginato, A.M. (2005) Pathogenesis of Gout. Annals of Internal Medicine, 143, 499-516.
http://dx.doi.org/10.7326/0003-4819-143-7-200510040-00009

[47]   Grayson, P.C., Kim, S.Y., Lavalley, M., et al. (2010) Hyperuricemia and Incident Hypertension: A Systematic Review and Meta-Analysis. Arthritis Care Research, 63, 102-110.

[48]   Kim, S.Y., Guevara, J.P., Kim, K.M., et al. (2009) Hyperuricemia and Risk of Stroke: A Systematic Review and Meta-Analysis. Arthritis Rheumatology, 61, 885-892.
http://dx.doi.org/10.1002/art.24612

[49]   Hsu, C.Y., Iribarren, C., McCulloch, C.E., et al. (2009) Risk Factors for End-Stage Renal Disease: 25-Year Follow-Up. Archives of Internal Medicine, 169, 342-350.
http://dx.doi.org/10.1001/archinternmed.2008.605

[50]   Mehrpour, M., Khuzan, M., Najimi, N., et al. (2012) Serum Uric Acid Level in Acute Stroke Patients. Medical Journal of The Islamic Republic of Iran, 26, 66-72.

[51]   Rho, Y.H., Woo, J.H., Choi, S.J., et al. (2008) Association between Serum Uric Acid and the Adult Treatment Panel III-Defined Metabolic Syndrome: Results from a Single Hospital Database. Metabolism, 57, 71-76.
http://dx.doi.org/10.1016/j.metabol.2007.08.008

[52]   Numata, T., Miyatake, N., Wada, J., et al. (2008) Comparison of Serum Uric Acid Levels between Japanese with and without Metabolic Syndrome. Diabetes Research and Clinical Practice, 80, e1-e5.
http://dx.doi.org/10.1016/j.diabres.2007.10.031

[53]   Cameron, M.A., Maalouf, N.M., Adams-Huet, B., et al. (2006) Urine Composition in Type 2 Diabetes: Predisposition to Uric Acid Nephrolithiasis. Journal of the American Society of Nephrology, 17, 1422-1428.
http://dx.doi.org/10.1681/ASN.2005121246

[54]   Sautin, Y.Y., Nakagawa, T., Zharikov, S., et al. (2007) Adverse Effects of the Classic Antioxidant Uric Acid in Adipocytes: NADPH Oxidase-Mediated Oxidative/Nitrosative Stress. American Journal of Physiology—Cell Physiology, 293, C584-C596.
http://dx.doi.org/10.1152/ajpcell.00600.2006

[55]   Zhu, Y.Z., Hu, Y.Q., Huang, T.L., et al. (2014) High Uric Acid Directly Inhibits Insulin Signalling and Induces Insulin Resistance. Biochemical and Biophysical Research Communications, 447, 707-714.
http://dx.doi.org/10.1016/j.bbrc.2014.04.080

[56]   Cheung, K.J., Tzameli, I., Pissios, P., et al. (2007) Xanthine Oxidoreductase Is a Regulator of Adipogenesis and PPARgamma Activity. Cell Metabolism, 5, 115-128.
http://dx.doi.org/10.1016/j.cmet.2007.01.005

[57]   Snaith, M.L. (2001) Gout: Diet and Uric Acid Revisited. The Lancet, 358, 525.
http://dx.doi.org/10.1016/S0140-6736(01)05745-2

[58]   Fam, A.G. (2002) Gout, Diet and the Insulin Resistance Syndrome. The Journal of Rheumatology, 29, 1350-1355.

[59]   Oh, H.J., Moon, S.H., Lee, J.W., et al. (2006) Relationship between Serum Uric Acid and Metabolic Syndrome. Journal of the Korean Academy of Family Medicine, 27, 699-705.

[60]   Ishizaka, N., Ishizaka, Y., Toda, E., et al. (2005) Association between Serum Uric Acid, Metabolic Syndrome and Carotid Atherosclerosis in Japanese Individuals. Arteriosclerosis, Thrombosis and Vascular Biology, 25, 1038-1044.
http://dx.doi.org/10.1161/01.ATV.0000161274.87407.26

[61]   Lin, S.D., Tsai, D.H. and Hsu, S.R. (2006) Association between Serum Uric Acid Level and Components of the Metabolic Syndrome. Journal of the Chinese Medical Association, 69, 512-516.
http://dx.doi.org/10.1016/S1726-4901(09)70320-X

[62]   Kim, S.K., Park, H.A., Nam, O.Y., et al. (2007) Risk of the Metabolic Syndrome According to the Level of the Uric Acid. Journal of the Korean Academy of Family Medicine, 28, 428-435.

[63]   Choi, H.K. and Ford, E.S. (2007) Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia. American Journal of Medicine, 120, 442-447.
http://dx.doi.org/10.1016/j.amjmed.2006.06.040

[64]   Onat, A., Uyarel, H., Hergenc, G., et al. (2006) Serum Uric Acid is a Determinant of Metabolic Syndrome in a Population-Based Study. American Journal of Hypertension, 19, 1055-1062.
http://dx.doi.org/10.1016/j.amjhyper.2006.02.014

[65]   Choi, H.K. and Ford, E.S. (2007) Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia. The American Journal of Medicine, 120, 442-447.

[66]   Nakagawa, T., Hu, H., Zharikov, S., et al. (2006) A Causal Role for Uric Acid in Fructose Induced Metabolic Syndrome. American Journal of Physiology—Renal Physiology, 290, F625-F631.
http://dx.doi.org/10.1152/ajprenal.00140.2005

 
 
Top